Thane based Health Tech Enabled Services Company IKS Health files DRHP with SEBI for the proposed IPO; Key Details here

IKS Health is into Technology Health Tech Enabled Services and is looking raise funds through Offer for Sale

IKS Health. Offer of Sale of 18,795,510 Equity Shares through public issue IPO

IKS Health IPO: Inventurus Knowledge Solutions Limited has filed Draft Red Herring Prospectus (DRHP) for proposed initial public offer (IPO) and raise funds through an offer of equity share capital having face value of Rs. 1 per share via initial public offering.

Promoters of IKS Health are Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Nishtha Jhunjhunwala Discretionary Trust and holds 69.73% stake in the company.

Key Details:

• Initial Public Offer comprising of a Offer for Sale of 18,795,510 Equity shares.
• ICICI Securities, Jefferies India, JM Financial, JP Morgan India, Nomura Financial Advisory have been appointed as lead merchant bankers for the proposed IPO.
• It has appointed Link Intime India Pvt. Ltd. as Registrar and Share transfer Agent.
• Company is yet to finalize issue size and some other important details relating to the IPO.

Details about upcoming IPO:
As per the details available in DRHP, fundraising will consist of an Equity Shares offer-for-sale (OFS) of up to 18,795,510 equity shares by Promoter group selling shareholders include Ashra Family Trust who will offload Up to 3,376,311 Equity Shares of the company...

ALSO READ: Hyderabad based Lifesciences Company Sai Life Sciences files DRHP with SEBI for the proposed IPO; Key Details here

Objects of the issue:
Company will not receive any proceeds from the Offer. The objects of the Offer are to (i) achieve the benefits of listing the Equity Shares on the Stock Exchange (ii) carry out the Offer for Sale.

About Company:
Established in 2006, Inventurus Knowledge Solutions (or IKS Health) is technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. Revenue Optimization Solutions are offered in the Pre-Visit Stage and include patient scheduling services and IKS EVE, at the Peri-Visit Stage and include clinical coding solutions and referral order management, at the Post Visit Stage that include Billing, Payment Posting, Denial Management, and Account Receivables Follow Up, IKS Optimix and at the In-Acute Settings Stage. As on Q2FY25 served 778 US based healthcare organisations.

ALSO READ: Gurugram based Fintech Company Mobikwik files DRHP with SEBI for the proposed IPO; Key Details here

About Industry:
As per the Zinnov Report, the outsourced services market in the technology-enabled healthcare provider space is growing rapidly as providers seek to boost efficiency and streamline operations. By leveraging technologyenabled service providers to handle workflows like billing, revenue cycle management, patient engagement, and data analytics, healthcare organizations can focus on core patient care activities and achieve higher quality care while maintaining operational excellence

Source: SEBI, BSE, NSE, DRHP, IKS Health, Industry Data

Disclaimer: Above article only publishes details about the IPO for educational purpose and doesn't solicit or invite any interest to invest. Please visit respective sources to verify and know more details about the IPO. We advise investors to take opinion from certified/SEBI registered experts before taking any investment decisions.